SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Hood C, Shanmugam VK. J. Nurse Pract. 2019; 15(10): 713-716.

Copyright

(Copyright © 2019, Elsevier Publishing)

DOI

10.1016/j.nurpra.2019.07.004

PMID

unavailable

Abstract

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease that is estimated to affect up to 4% of the population. Patients with HS are at increased risk for anxiety, depression, and suicide. Despite the prevalence of this disease, there is still underrecognition and often a delay in diagnosis. For successful treatment, a multimodal approach is recommended. Effective treatments include excision surgery, tumor necrosis factor (TNF) inhibitor therapy, antibiotics, hormonal therapy, and metformin. Supportive treatments such as wound care, effective pain management, and advising on weight loss and smoking cessation are also important components of successful disease management. © 2019 Elsevier Inc.


Language: en

Keywords

dermatology; abscess; hidradenitis suppurativa; TNF inhibitor

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print